Loading...
XASX
CNB
Market cap64mUSD
Jul 08, Last price  
0.43AUD
1D
1.18%
1Q
86.96%
IPO
65.38%
Name

Carnaby Resources Ltd

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
21.22%
Rev. gr., 5y
-6.94%
Revenues
0k
000004,380,713000
Net income
-12m
L-1.21%
-117,582-602,52000-3,123,086371,382-8,216,492-12,233,779-12,086,344
CFO
-12m
L+6.85%
-3,872-201,30200-2,532,694677,681-8,161,925-11,272,590-12,045,297
Earnings
Sep 17, 2025

Profile

Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records. The company offers advisory and auditing solution, such as desktop analysis, data maturity index, and physical audits. It serves customers through channel partners. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. Beamtree Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.
IPO date
Aug 30, 2016
Employees
95
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
13,002
12,780
Unusual Expense (Income)
NOPBT
(13,002)
(12,780)
NOPBT Margin
Operating Taxes
3
Tax Rate
NOPAT
(13,002)
(12,780)
Net income
(12,086)
-1.21%
(12,234)
48.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
(7)
18,649
BB yield
0.01%
-12.03%
Debt
Debt current
(88)
19
Long-term debt
84
19
Deferred revenue
Other long-term liabilities
496
375
Net debt
(10,793)
(27,265)
Cash flow
Cash from operating activities
(12,045)
(11,273)
CAPEX
(4,411)
(190)
Cash from investing activities
(3,506)
586
Cash from financing activities
(173)
19,680
FCF
(31,320)
(12,780)
Balance
Cash
10,312
26,941
Long term investments
478
362
Excess cash
10,789
27,303
Stockholders' equity
26,777
31,608
Invested Capital
16,549
4,699
ROIC
ROCE
EV
Common stock shares outstanding
163,974
147,609
Price
0.48
-54.29%
1.05
16.67%
Market cap
78,707
-49.22%
154,990
33.31%
EV
67,915
127,724
EBITDA
(13,002)
(12,686)
EV/EBITDA
Interest
7
9
Interest/NOPBT